Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now small index

Aortic Dissection clinical trials

9 of 13 indexed Aortic Dissection trials are currently recruiting.

Corpus placement: #1,315 of 28,707 conditions by registered trial count.

13 US clinical trials · 9 currently recruiting · #1,315 of 28,707 conditions by registered trial count

Aortic Dissection: 13 US clinical trials tracked, 9 recruiting.

Aortic Dissection is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. The most active sponsor is W.L.Gore & Associates, running 2 of these trials.

Enrollment posture brief

Registry condition aortic-dissection

OPEN 9 | RECR 69% | LATE 0 | EARLY 0 | RANK #1315 | SPON 2

Nearest open-share peer: Ankle Fractures (69% recruiting · 13 trials)

Aortic Dissection (this)69%ACL Injury61.5%Acute Biphenotypic Leukemia46.2%Accidental Falls30.8%Actinic Keratoses23.1%
Open-enrollment share among volume-matched conditions near Aortic Dissection

Aortic Dissection lists 9 open slots (69% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Aortic Dissection on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Aortic Dissection is recruiting above its size-band peers.

    9 of 13 indexed trials (69.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Aortic Dissection research.

    W.L.Gore & Associates accounts for 2 of 13 trials (15.4%). 12 distinct sponsors appear on at least one study for this condition label.

  3. Typical Aortic Dissection enrolment sits around 200 participants.

    Median target enrolment is 200 among the 12 trials that report a genuine target (sentinel values excluded). 3 of those (25%) plan for fewer than 100 participants.

  4. Aortic Dissection splits between interventional and observational designs.

    8 interventional and 5 observational studies make up this index (61.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Open and recent trials

13 total, page 1 of 1

RECRUITING open-ended (no fixed target)

Cardiovascular Health Improvement Project

University of Michigan

NCT02306200

RECRUITING 5,000 participants

Montalcino Aortic Consortium: Precision Medicine for Heritable Thoracic Aortic Disease

The University of Texas Health Science Center, Houston

NCT04005976

RECRUITING NA 590 participants

B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair

Eric Roselli, M. D.

NCT04747626

RECRUITING NA 410 participants

Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies

University of Alabama at Birmingham

NCT02043691

RECRUITING 260 participants

Valved Graft PMCF Study

Abbott Medical Devices

NCT04754217

RECRUITING NA 180 participants

Safety and Efficacy of Endovascular Repair of Complex Aortic Pathology With Physician-modified Endovascular Grafts (PMEGs)

Beth Israel Deaconess Medical Center

NCT04746677

RECRUITING NA 112 participants

GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections

W.L.Gore & Associates

NCT06827990

RECRUITING NA 110 participants

NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness

Endospan

NCT04471909

RECRUITING NA 20 participants

Feasibility of Endovascular Repair Of Ascending Aortic Pathologies

Rodney A. White, M.D.

NCT02201589

ACTIVE NOT RECRUITING 352 participants

Thoraflex Hybrid and Relay Extension Post-Approval Study

Vascutek

NCT05639400

ACTIVE NOT RECRUITING 200 participants

Registry of Patients With Acute/Subacute Type B Aortic Dissection Treated by Means of the STABILISE Technique (STABILISE)

IRCCS San Raffaele

NCT03707743

ACTIVE NOT RECRUITING 21 participants

ARISE: Evaluation of the GORE® Ascending Stent Graft in the Treatment of DeBakey Type I/II Aortic Dissection

W.L.Gore & Associates

NCT02380716

COMPLETED NA 50 participants

Study to Evaluate the Clinical Performance of the Valiant Thoracic Stent Graft With the Captivia Delivery System (Valiant Captivia) for the Treatment of Acute, Complicated Type B Aortic Dissections

Medtronic Cardiovascular

NCT01114724

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on Aortic Dissection records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Valiant Thoracic Stent Graft with the Captivia Delivery System Device
1 trials
RelayPro NBS Device
1 trials
Thoraflex Hybrid Device
1 trials
GORE® Ascending Stent Graft Device
1 trials
Endovascular aortic repair with a physician-modified endovascular graft (PMEG) Device
1 trials
GORE® Ascending Stent Graft (ASG device) Device
1 trials
NEXUS Aortic Stent Graft System Device
1 trials
CAVGJ Device
1 trials

US sites by state

Facility locations filed on Aortic Dissection trials. A trial with sites in several states counts in each.

California 7 trials
North Carolina 6 trials
Michigan 6 trials
Massachusetts 6 trials
New York 5 trials
Alabama 5 trials
Texas 4 trials
Pennsylvania 4 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Aortic Dissection page

13 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Aortic Dissection condition card totals 13 registered trials; most-linked intervention Valiant Thoracic Stent Graft with the Captivia Delivery System; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.